CRISPR

CRISPR1-vcanb

ID
ZDB-CRISPR-250429-10
Name
CRISPR1-vcanb
Previous Names
None
Target
Sequence
5' - GGGTAAAGGGTAGCCCGTCCGG - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
pd3002 vcanb
Expression
Gene expression in Wild Types + CRISPR1-vcanb
No data available
Phenotype
Phenotype resulting from CRISPR1-vcanb
No data available
Phenotype of all Fish created by or utilizing CRISPR1-vcanb
Phenotype Fish Conditions Figures
otic vesicle protrusion ab-cs-56 labeling decreased amount, abnormal WT + CRISPR1-vcanb + CRISPR2-vcana + CRISPR2-vcanb + CRISPR3-vcana + CRISPR3-vcanb + CRISPR4-vcana standard conditions Fig. 4 with image from Mori et al., 2024
otic vesicle protrusion extracellular matrix organization decreased process quality, abnormal WT + CRISPR1-vcanb + CRISPR2-vcana + CRISPR2-vcanb + CRISPR3-vcana + CRISPR3-vcanb + CRISPR4-vcana standard conditions Fig. 4 with image from Mori et al., 2024
semicircular canal morphogenesis decreased process quality, abnormal hm40Tg + CRISPR1-vcanb + CRISPR2-vcana + CRISPR2-vcanb + CRISPR3-vcana + CRISPR3-vcanb + CRISPR4-vcana standard conditions Fig. 3 with image from Mori et al., 2024
otic vesicle posterior protrusion decreased length, abnormal hm40Tg + CRISPR1-vcanb + CRISPR2-vcana + CRISPR2-vcanb + CRISPR3-vcana + CRISPR3-vcanb + CRISPR4-vcana standard conditions Fig. 3 with image from Mori et al., 2024
otic vesicle lateral protrusion decreased length, abnormal hm40Tg + CRISPR1-vcanb + CRISPR2-vcana + CRISPR2-vcanb + CRISPR3-vcana + CRISPR3-vcanb + CRISPR4-vcana standard conditions Fig. 3 with image from Mori et al., 2024
otic vesicle anterior protrusion decreased length, abnormal hm40Tg + CRISPR1-vcanb + CRISPR2-vcana + CRISPR2-vcanb + CRISPR3-vcana + CRISPR3-vcanb + CRISPR4-vcana standard conditions Fig. 3 with image from Mori et al., 2024
otic vesicle posterior protrusion decreased length, abnormal vcanapd3001/pd3001; vcanbpd3002/pd3002 standard conditions Fig. 3 with image from Mori et al., 2024
semicircular canal morphogenesis decreased process quality, abnormal vcanapd3001/pd3001; vcanbpd3002/pd3002 standard conditions Fig. 3 with image from Mori et al., 2024
otic vesicle lateral protrusion decreased length, abnormal vcanapd3001/pd3001; vcanbpd3002/pd3002 standard conditions Fig. 3 with image from Mori et al., 2024
heart edematous, abnormal vcanapd3001/pd3001; vcanbpd3002/pd3002 standard conditions Fig. 3 with image from Mori et al., 2024
otic vesicle anterior protrusion decreased length, abnormal vcanapd3001/pd3001; vcanbpd3002/pd3002 standard conditions Fig. 3 with image from Mori et al., 2024
Citations